DK1123704T3 - Midler til spinalstenose - Google Patents

Midler til spinalstenose

Info

Publication number
DK1123704T3
DK1123704T3 DK99940567T DK99940567T DK1123704T3 DK 1123704 T3 DK1123704 T3 DK 1123704T3 DK 99940567 T DK99940567 T DK 99940567T DK 99940567 T DK99940567 T DK 99940567T DK 1123704 T3 DK1123704 T3 DK 1123704T3
Authority
DK
Denmark
Prior art keywords
hydrogen atom
remedies
spinal stenosis
halogen atom
atom
Prior art date
Application number
DK99940567T
Other languages
English (en)
Inventor
Toru Kawamura
Tomoyuki Maruyama
Toshiaki Akira
Hideaki Kido
Norifumi Nakamura
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of DK1123704T3 publication Critical patent/DK1123704T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/501Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99940567T 1998-09-01 1999-08-30 Midler til spinalstenose DK1123704T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24688698 1998-09-01
EP99940567A EP1123704B1 (en) 1998-09-01 1999-08-30 Remedies for spinal canal stenosis

Publications (1)

Publication Number Publication Date
DK1123704T3 true DK1123704T3 (da) 2004-11-01

Family

ID=17155219

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99940567T DK1123704T3 (da) 1998-09-01 1999-08-30 Midler til spinalstenose

Country Status (15)

Country Link
US (1) US6369061B1 (da)
EP (1) EP1123704B1 (da)
JP (1) JP4366865B2 (da)
KR (1) KR100573376B1 (da)
CN (1) CN1137686C (da)
AT (1) ATE272401T1 (da)
AU (1) AU5445699A (da)
CA (1) CA2342198C (da)
DE (1) DE69919191T2 (da)
DK (1) DK1123704T3 (da)
ES (1) ES2221421T3 (da)
PT (1) PT1123704E (da)
RU (1) RU2229297C2 (da)
TW (1) TW544312B (da)
WO (1) WO2000012091A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004089411A1 (ja) * 2003-04-03 2006-07-06 小野薬品工業株式会社 脊柱管狭窄症治療剤
EP1698339A4 (en) * 2003-12-26 2009-06-17 Nissan Chemical Ind Ltd INHIBITOR OF NEUTROPHILY
BRPI0507518A8 (pt) * 2004-02-09 2015-12-01 Nissan Chemical Ind Ltd Inibidor de hiperplasia vascular da íntima
JP2012513446A (ja) 2008-12-23 2012-06-14 ファイザー・インク 脊椎管狭窄症を処置するための薬剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69132329T2 (de) 1990-04-25 2000-11-30 Nissan Chemical Ind Ltd Pyridazinonderivat
JP3806945B2 (ja) * 1994-01-21 2006-08-09 三菱ウェルファーマ株式会社 ヒト由来アンチトロンビン−iiiの新規用途
CA2181901C (en) 1994-01-25 2005-09-13 Keizo Tanikawa Pyridazinone derivatives
IL112695A (en) * 1994-02-22 1999-04-11 Green Cross Corp Pharmaceutical compositions containing pyridazinone derivatives
JPH09227411A (ja) * 1996-02-26 1997-09-02 Sumitomo Pharmaceut Co Ltd 脊髄損傷による神経障害治療剤

Also Published As

Publication number Publication date
ATE272401T1 (de) 2004-08-15
KR20010086361A (ko) 2001-09-10
CN1137686C (zh) 2004-02-11
KR100573376B1 (ko) 2006-04-25
RU2229297C2 (ru) 2004-05-27
EP1123704A4 (en) 2001-10-10
CA2342198A1 (en) 2000-03-09
WO2000012091A1 (en) 2000-03-09
TW544312B (en) 2003-08-01
ES2221421T3 (es) 2004-12-16
EP1123704A1 (en) 2001-08-16
AU5445699A (en) 2000-03-21
PT1123704E (pt) 2004-10-29
US6369061B1 (en) 2002-04-09
JP4366865B2 (ja) 2009-11-18
DE69919191T2 (de) 2005-07-28
CN1325307A (zh) 2001-12-05
DE69919191D1 (de) 2004-09-09
CA2342198C (en) 2007-08-28
EP1123704B1 (en) 2004-08-04

Similar Documents

Publication Publication Date Title
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
TW200420542A (en) A compound having TGF β inhibition activity and a medicinal composition containing the same
FI873631A (fi) --alkyl-4-amino-3-kinolinmetanoler och 1-(4-aralkylamino-3-kinolinyl)alkanoler, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
DK0862562T3 (da) Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler
NZ313185A (en) 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
DE60121461D1 (de) Kondensierte pyridoindolderivate
ID26622A (id) Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide
AU7810787A (en) 6-{2-(3-phenoxy-2-hydroxy-propylamino)-propyl-amino}-5- methyl-pyrizine-3-one derivatives useful as antihyper- tensive agents
ATE231487T1 (de) 2-phenoxyanilin-derivate
BR0013943A (pt) Conjugados de glicopiranosìdeos de 2-(4-hidróxi-fenil)-1-[4-(2-amin-1-il-etóxi)-benzil]-1h-indo l-5-óis
DK1123704T3 (da) Midler til spinalstenose
DE69513679T2 (de) 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
CA2228078A1 (en) Composition for oral administration containing pyridazinone compounds
ATE238300T1 (de) (3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl)-3-(1 - indol-3-yl)-alkylamine
RU2001108574A (ru) Терапевтический агент для лечения стеноза позвоночного канала
EP0919233B8 (en) Therapeutic agent for kidney diseases